US markets experienced significant volatility as former President Donald Trump's proposed tariff plans sparked a massive sell-off in technology shares, with AI giant Nvidia leading the declines amid renewed China trade tensions.
Donald Trump's dramatic weight loss sparks pharmaceutical frenzy as Novo Nordisk faces unprecedented demand for revolutionary diabetes medications.
Michael Burry of 'The Big Short' fame reveals he's betting against AI stocks, warning of an impending bubble burst that could mirror previous market crashes.
World stock markets experience dramatic sell-off amid growing fears that the artificial intelligence investment boom has reached unsustainable levels, wiping billions from company valuations.
World stock markets plunge as artificial intelligence stock valuations face reality check. Experts warn of overinflated tech sector and potential economic fallout.
Chinese private equity firm Boyu Capital dramatically reduces its Starbucks holdings amid challenging market conditions, signalling shifting investor confidence in the coffee giant's China prospects.
Nvidia has surged past Amazon in market capitalisation, marking a pivotal moment in tech industry leadership as AI chip demand continues to reshape the global economic landscape.
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
London's FTSE 100 index suffers significant losses as global markets tumble, with mining and banking stocks leading the downturn amid economic uncertainty.
Marks & Spencer shares experienced their sharpest decline since March 2020 after the retail bellwether warned of weaker profits, sending shockwaves through the UK retail sector.
Britain's housing market shows unexpected resilience as prices climb in October, while Asian markets deliver mixed performance ahead of key tech earnings reports.
Apple's latest earnings reveal surprising iPhone demand weakness, sending shares tumbling as analysts question the tech giant's growth strategy in challenging economic times.
Swiss food giant Nestlé experiences unprecedented investor confidence as strategic shifts and market positioning create remarkable momentum in European markets.
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Microsoft's latest earnings reveal the costly impact of a major Azure cloud outage, while Xbox sales decline continues. Discover how the tech giant navigated these challenges in Q1 2025.
Google's parent company Alphabet reports staggering Q3 2025 results with revenue hitting $86.1bn, driven by AI breakthroughs and cloud computing dominance. Discover how the tech giant continues to outperform market predictions.
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Nvidia's staggering market valuation leap sees it overtake Amazon and Alphabet, with the AI chipmaker's stock reaching unprecedented heights amid surging demand for artificial intelligence technology.
Nvidia's stock soars to unprecedented heights as demand for AI processors transforms the tech landscape, positioning the company as a dominant force in artificial intelligence computing.
Apple faces significant market pressure as iPhone revenue growth stalls, raising questions about the company's future strategy in an increasingly competitive smartphone market.
Retail traders show surprising resilience as AI stock volatility shakes markets, adopting 'buy the dip' strategies while experts warn of bubble risks.
Exclusive analysis reveals why JP Morgan's David Schwimmer believes Microsoft stock faces significant headwinds despite AI optimism and strong market performance.
Shadow Chancellor Rachel Reeves sounds alarm on investment risks as experts reveal why traditional savings approaches may no longer protect your financial future in today's volatile market.
London's Alternative Investment Market (AIM) has outperformed global rivals, delivering exceptional returns and cementing its status as the premier growth market for innovative companies.
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Investment director Russ Mould reveals how London's junior AIM market has outperformed Wall Street's Nasdaq, while FTSE 100 giants Barclays and Lloyds face contrasting fortunes in challenging economic conditions.
American regional banks face renewed turmoil as NYCB's financial warning triggers sector-wide selloff, raising fears of another banking crisis and Federal Reserve intervention.
Money Saving Expert founder reveals crucial ISA deadline and explains how Rachel Reeves' potential tax changes could affect your savings. Essential reading for UK investors.
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
Global financial institutions warn of artificial intelligence stock market bubble as investors pour billions into AI companies amid growing economic concerns.